Peter Ordentlich, Chief Scientific Officer at Syndax Pharmaceuticals Inc (SNDX), sold 1,412 shares at $16.65 ($24K) on 2022-02-01, disclosed to the SEC on 2022-02-03.
Open-market sale of $24k SNDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2022-12-02 | $821K | — | Filing → |
| SNDX | SELL | 2022-08-26 | $1.3M | — | Filing → |
| SNDX | SELL | 2020-11-25 | $1.4M | — | Filing → |